Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-25-013839
Filing Date
2025-04-30
Accepted
2025-04-30 16:00:34
Documents
19
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A urgn20241231_10ka.htm   iXBRL 10-K/A 486772
2 EXHIBIT 31.3 ex_806545.htm EX-31.3 5021
3 EXHIBIT 31.4 ex_806546.htm EX-31.4 4923
8 ceocompensation.jpg GRAPHIC 42768
  Complete submission text file 0001437749-25-013839.txt   920187

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20241231.xsd EX-101.SCH 5403
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE urgn-20241231_def.xml EX-101.DEF 16695
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20241231_lab.xml EX-101.LAB 35604
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20241231_pre.xml EX-101.PRE 21154
21 EXTRACTED XBRL INSTANCE DOCUMENT urgn20241231_10ka_htm.xml XML 13151
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38079 | Film No.: 25894727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)